Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2

Status

Unknown 4Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 2OTHER 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 4Biliary Tract Neoplasms 3Pancreatic Neoplasms 2Carcinoma, Neuroendocrine 2Carcinoma, Hepatocellular 2Advanced Colorectal Cancer 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Solid Tumor 1Sarcoma 1Refractory Metastatic Digestive System Carcinoma 1Neuroendocrine Tumor Grade 3 1Head and Neck Cancers - Salivary Gland 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Breast Neoplasms 1Advanced Non-Small Cell Lung Cancer 1

Interventions

Etoposide 23Cisplatin 15Carboplatin 13Irinotecan 12apatinib 11anlotinib 10durvalumab 7Topotecan 6toripalimab 4surufatinib 4sintilimab 4atezolizumab 4Temozolomide 4Drug Therapy 4tislelizumab 3lobaplatin 3camrelizumab 3Simvastatin 3Radiotherapy 3Ifosfamide 3Albumin-Bound Paclitaxel 3pembrolizumab 2pegylated granulocyte colony-stimulating factor 2olaparib 2niraparib 2isophosphamide mustard 2avelumab 2X-Rays 2Platinum 2Nivolumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Small Cell Lung Carcinoma × surufatinib × Clear all
NCT05882630 2023-05-31

Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer

Fujian Cancer Hospital

Phase 1/2 Unknown
39 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05595889 2022-11-29

Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer

Fujian Cancer Hospital

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04996771 2022-11-14

Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer

Sun Yat-sen University

Phase 1/2 Unknown
88 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05527821 2022-09-06

Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
36 enrolled
GastrointestinalThoracic

Stomach Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡